Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 101

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 101
---
     | Total Consideration 
 Amount              |            |     | Percent |       |   |     | Average Price Per Ordinary 
 Share                      |      |
|:----------------------|:----|:-------|----------:|:----|:--------|------:|:--|:----|:--------------------|-----------:|:----|:--------|------:|:--|:----|:---------------------------|-----:|
| Existing shareholders |     |        | 3,929,378 |     |         |       | % |     | $                   | 36,197,100 |     |         |       | % |     | $                          | 9.21 |
| New investors         |     |        |   909,090 |     |         |       | % |     | $                   | 10,000,000 |     |         |       | % |     | $                          | 11.0 |
| Total                 |     |        | 4,838,468 |     |         | 100.0 | % |     |                     | 46,197,100 |     | $       | 100.0 | % |     | $                          | 9.54 |

A $0.25 increase (decrease) in the assumed initial public offering
price of $11.00 per Ordinary Share (the midpoint of the price range set forth on the cover page of this prospectus) would increase
(decrease) the total consideration paid by investors participating in this offering, total consideration paid by all shareholders and
the average price per share paid by all shareholders by approximately $0.27 million, $0.27 million and $0.06 , respectively, assuming
that the number of Ordinary Shares offered by us, as set forth on the cover page of this prospectus, remains the same and before deducting
the estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, a 100,000 share increase
(decrease) in the number of Ordinary Shares offered by us, as set forth on the cover of this prospectus, would increase (decrease) the
total consideration paid by investors participating in this offering, total consideration paid by all shareholders and the average price
per share paid by all shareholders by approximately $1.07 million, $1.07 million and $0.19, respectively, assuming the assumed
public offering price of $11.00 per Ordinary Share remains the same, and after deducting